Puma Biotechnology Inc (NYSE:PBYI) just announced its abstract for an upcoming 2016 San Antonio Breast Cancer Symposium (SABCS), which will ...
News
- Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity
- Cholesterol drug shows promise to help reverse heart disease
The new ones are biotech drugs that are expensive to make — Repatha costs $14,000 a year and insurers often won't pay. They must be given as ...
- Active biotech company shares in the news: Immunomedics Inc. (NASDAQ:IMMU), Trevena, Inc ...
... presentation at the 2016 San Antonio Breast Cancer Symposium (SABCS) to be held at the Henry B. Gonzalez Convention Center in San Antonio, ...
- Sizzling Stock Alert - Puma Biotechnology, (NYSE:PBYI), Zimmer Biomet Holdings, (NYSE:ZBH)
Puma Biotechnology Inc (NYSE:PBYI) traded 6,932,205 shares on last ... Symposium (SABCS), December 6 – 10, 2016, in San Antonio, Texas.
- SA bioscience industry launches new website to spur greater collaboration
The San Antonio Medical Foundation has taken a critical step in helping showcase the level of biomedical research occurring in the Alamo City, launching a first-of-its-kind website that…